246 related articles for article (PubMed ID: 10356275)
21. Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice.
Greenberg MS; Burton GA; Fisher JW
Toxicol Appl Pharmacol; 1999 Feb; 154(3):264-78. PubMed ID: 9931286
[TBL] [Abstract][Full Text] [Related]
22. Use of tissue disposition data from rats and dogs to determine species differences in input parameters for a physiological model for perchloroethylene.
Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV
Environ Res; 1994 Oct; 67(1):54-67. PubMed ID: 7925194
[TBL] [Abstract][Full Text] [Related]
23. Tissue dosimetry expansion and cross-validation of rat and mouse physiologically based pharmacokinetic models for trichloroethylene.
Keys DA; Bruckner JV; Muralidhara S; Fisher JW
Toxicol Sci; 2003 Nov; 76(1):35-50. PubMed ID: 12915716
[TBL] [Abstract][Full Text] [Related]
24. Metabolism and cytotoxicity of naphthalene oxide in the isolated perfused mouse lung.
Kanekal S; Plopper C; Morin D; Buckpitt A
J Pharmacol Exp Ther; 1991 Jan; 256(1):391-401. PubMed ID: 1988668
[TBL] [Abstract][Full Text] [Related]
25. Physiologically based pharmacokinetic modeling of cyclotrimethylenetrinitramine in male rats.
Krishnan K; Crouse LC; Bazar MA; Major MA; Reddy G
J Appl Toxicol; 2009 Oct; 29(7):629-37. PubMed ID: 19629953
[TBL] [Abstract][Full Text] [Related]
26. A physiological toxicokinetic model for inhaled propylene oxide in rat and human with special emphasis on the nose.
Csanády GA; Filser JG
Toxicol Sci; 2007 Jan; 95(1):37-62. PubMed ID: 17062723
[TBL] [Abstract][Full Text] [Related]
27. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
Ress NB;
Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
[TBL] [Abstract][Full Text] [Related]
28. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
29. Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action.
Cruzan G; Bus J; Banton M; Gingell R; Carlson G
Regul Toxicol Pharmacol; 2009 Nov; 55(2):205-18. PubMed ID: 19589367
[TBL] [Abstract][Full Text] [Related]
30. A physiologically based pharmacokinetic model for 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in the rat: tissue distribution and CYP1A induction.
Kedderis LB; Mills JJ; Andersen ME; Birnbaum LS
Toxicol Appl Pharmacol; 1993 Jul; 121(1):87-98. PubMed ID: 8337704
[TBL] [Abstract][Full Text] [Related]
31. Development and evaluation of a harmonized physiologically based pharmacokinetic (PBPK) model for perchloroethylene toxicokinetics in mice, rats, and humans.
Chiu WA; Ginsberg GL
Toxicol Appl Pharmacol; 2011 Jun; 253(3):203-34. PubMed ID: 21466818
[TBL] [Abstract][Full Text] [Related]
32. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
33. Protective effect of aqueous garlic extract against naphthalene-induced oxidative stress in mice.
Omurtag GZ; Güranlioğlu FD; Sehirli O; Arbak S; Uslu B; Gedik N; Sener G
J Pharm Pharmacol; 2005 May; 57(5):623-30. PubMed ID: 15901351
[TBL] [Abstract][Full Text] [Related]
34. Development of a microscale cell culture analog to probe naphthalene toxicity.
Viravaidya K; Sin A; Shuler ML
Biotechnol Prog; 2004; 20(1):316-23. PubMed ID: 14763858
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of two different metabolic hypotheses for dichloromethane toxicity using physiologically based pharmacokinetic modeling for in vivo inhalation gas uptake data exposure in female B6C3F1 mice.
Evans MV; Caldwell JC
Toxicol Appl Pharmacol; 2010 May; 244(3):280-90. PubMed ID: 20153349
[TBL] [Abstract][Full Text] [Related]
36. Development of a physiologically based pharmacokinetic model of 2-methoxyethanol and 2-methoxyacetic acid disposition in pregnant rats.
Hays SM; Elswick BA; Blumenthal GM; Welsch F; Conolly RB; Gargas ML
Toxicol Appl Pharmacol; 2000 Feb; 163(1):67-74. PubMed ID: 10662606
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of 2-methoxyethanol and 2-methoxyacetic acid in the pregnant mouse: a physiologically based mathematical model.
Clarke DO; Elswick BA; Welsch F; Conolly RB
Toxicol Appl Pharmacol; 1993 Aug; 121(2):239-52. PubMed ID: 8346541
[TBL] [Abstract][Full Text] [Related]
38. In vivo metabolism of isomeric naphthalene oxide glutathione conjugates.
Buonarati M; Jones AD; Buckpitt A
Drug Metab Dispos; 1990; 18(2):183-9. PubMed ID: 1971571
[TBL] [Abstract][Full Text] [Related]
39. Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approach.
Chiu WA; Okino MS; Evans MV
Toxicol Appl Pharmacol; 2009 Nov; 241(1):36-60. PubMed ID: 19660485
[TBL] [Abstract][Full Text] [Related]
40. Efflux of naphthalene oxide and reactive naphthalene metabolites from isolated hepatocytes.
Richieri PR; Buckpitt AR
J Pharmacol Exp Ther; 1987 Aug; 242(2):485-92. PubMed ID: 3612547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
